Here are relevant reports on : clinical-documentation-improvement-market
-
Mid-Revenue Cycle Management/Clinical Documentation Improvement Market by Product & Service (Clinical Documentation, Clinical Coding (NLP, Structure Input), Charge Capture, CDI, DRG, Pre-Bill Review), End User, and Region - Global Forecast to 2023
The clinical documentation improvement market is projected to reach USD 4.5 billion by 2023, at a CAGR of 7.9%. Market growth is largely driven by the increasing utilization of mid-RCM solutions to reduce healthcare costs, check the loss of revenue due to medical billing and coding errors, resolve issues raised by the decline in reimbursement rates, manage ever-increasing amounts of unstructured data, and maintain regulatory compliance. Some of the prominent players in this market are are 3M Company (US), Optum (US), Nuance (US), M*Modal (US), nThrive (US), Dolbey Systems (US), Streamline Health (US), Vitalware (US), Chartwise (US), Craneware (US), Epic Systems (US), Cerner (US), eZDI Inc. (US), Iodine Software (US), Flash Code (US), and TruCode (US).
- Published: January 2019
- Price: $ 4950
- TOC Available:
-
Gel Documentation Systems Market by Product (Instruments (Digital), Software), Light Source (Laser, LED, UV), Detection (Chemiluminescence), Application (Nucleic Acid), End User (Academic Institutes, Biotechnology Companies) & Region - Global Forecast to 2023
The gel documentation systems market is projected to reach USD 304 million by 2023, at a CAGR of 3.3%. Growth in the gel documentation systems market is mainly driven by the increasing prevalence of infectious and chronic disease, and rising research & development expenditure in the pharmaceutical and biotechnology companies. The major players in the gel documentation systems market are GE Healthcare (US), Bio-Rad Laboratories, inc. (US), Thermo Fisher Scientific (US), LI-COR Biosciences (US), Endress+Hauser Management AG (Switzerland), Vilber Lourmat (France), Scientific Digital Imaging plc (UK), Bio-Techne (US), Cleaver Scientific (US), and Azure Biosystems (US).
- Published: December 2018
- Price: $ 4950
- TOC Available:
-
Home Healthcare Software - Product & Service Market - Application (Clinical, Non - Clinical), Usage (Laptop, Smartphone), Product (Agency, Clinical Management System, Telehealth, Hospice), Delivery (Web - Based, On - Premises, Cloud), End User - Global Forecast to 2018
The global home healthcare software and services market is estimated to reach $6.4 billion by 2018, at a CAGR of 13.4% between 2013 and 2018. The market will be driven by skyrocketing healthcare cost, spiralling aging population that increases the incidences of chronic disorders, hospital readmission reduction program by U.S., shortage of nursing and doctors staff, OASIS documentation, and favorable government initiatives.
- Published: May 2014
- Price: $ 4950
- TOC Available:
-
Sleep Software Market by Function (Sleep Tracking, Analysis, Disorder Management, Improvement), Indication (Insomnia, Sleep Apnea), Offering (Platforms, Apps (Mobile)), End-user (Providers, Individual), Deployment, Type, & Region - Global Forecast to 2030
The global sleep software market, valued at US$776.2 million in 2023, stood at US$878.9 million in 2024 and is projected to advance at a resilient CAGR of 10.1% from 2024 to 2030, culminating in a forecasted valuation of US$1,569.2 million by the end of the period. The market growth is mainly fueled by increased awareness of sleep health and the rising adoption of wearable technologies and AI-based solutions.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Industrial Services Market by SCADA, DCS, MES, Robotics, PLC, Safety System, Industrial PC, 3D Printing, Motor & Drive, PLC, HMI, Service Type (Engineering & Consulting, Installation & Commissioning, Improvement & Maintenance) - Global Forecast to 2030
The industrial services market is expected to grow from USD 34.41 billion in 2025 to USD 54.69 billion by 2030, at a compound annual growth rate (CAGR) of 9.7% during the forecast period. The Key Players ABB (Switzerland), Honeywell International Inc. (US), Rockwell Automation (US), Schneider Electric (France), Siemens (Germany), GE Vernova (US), Emerson Electric Co. (US), Yokogawa Electric Corporation (Japan), Eaton (Ireland), Mitsubishi Electric Corporation (Japan), ATS Corporation (sCanada), Metso (Finland), Yaskawa Electric Corporation (Japan), SKF (Sweden), and Atlas Copco AB (Sweden).
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Plant Breeding and CRISPR Plants Market by Type (Conventional Breeding and Biotechnological Method), Trait (Herbicide Tolerance, Disease Resistance, Yield & Grain Size Improvement, Temperature Tolerance), Technology, Application, and Region - Global Forecast to 2030
The global plant breeding and CRISPR plants market is projected to reach USD 13.86 billion by 2030, growing at a CAGR of 9.2% during the forecast period. The report profiles key players such as Bayer AG (Germany), KWS SAAT SE & Co. KGaA (Germany), Corteva (US), BASF (Germany), UPL (India), Rijk Zwaan Zaadteelt en Zaadhandel B.V. (Netherlands), Eurofins Scientific (Luxembourg), SGS Société Générale de Surveillance SA. (Switzerland), Sanatech Seed Co.,Ltd. (Japan), and Pairwise (US).
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Companion Animal Diagnostics Market by Product (Consumables, Instruments), Technology (Clinical Biochemistry, Hematology), Application (Clinical Pathology, Virology), Animal (Dogs, Cats, Horses), End User (Diagnostic Laboratories) - Global Forecast to 2029
The global companion animal diagnostics market, valued at US$2.75 billion in 2023, stood at US$2.99 billion in 2024 and is projected to advance at a resilient CAGR of 8.8% from 2024 to 2029, culminating in a forecasted valuation of US$4.55 billion by the end of the period. The growing demand for rapid tests and portable instruments for point-of-care (POC) services is offering growth opportunities for players in the companion animal diagnostics market.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Coagulation Analyzer Market by Product (Clinical Laboratory Analyzers, Consumables, Reagents, Systems), Test (PT Test, APT Test, D-Dimer Test), Technology (Optical, Mechanical), End User (Hospitals, Clinical Laboratory) & Region - Global Forecast to 2030
Global coagulation analyzers market valued at $3516.0M in 2024, reached $3,770.9M in 2025, and is projected to grow at a robust 7.2% CAGR, hitting $5,335.9M by 2030. The market is experiencing steady growth, primarily driven by the increasing prevalence of blood clotting disorders such as hemophilia and deep vein thrombosis. As the global population ages and chronic illnesses become more common, the demand for quick and accurate diagnostic tools continues to rise.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Endocrine Testing Market by Type (Thyroid, Insulin, HCG, Prolactin, Progesterone, LH, FSH), Technology (Immunoassay, Tandem Mass Spectroscopy, Clinical Chemistry), End User (Hospitals, Clinical Laboratories) - Global Forecast to 2027
The global Endocrine Testing Market is expected to reach USD xx billion by 2027 from USD xx billion in 2022, at a CAGR of xx%. The growth in this market is driven by the increasing prevalence of the endocrine disorders such as thyroid imbalance, diabetes, Polycystic Ovary Syndrome, etc. Also, the increasing government funding and rising awareness for the endocrine hormone tests for the diagnosis and management of the endocrine disorder have also fueled the growth of the market.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Clinical Informatics Market by Function (EHR, Clinical Workflow, PHM, Telehealth, CDSS, Diagnostic, Analytics), Therapeutic Area (Onco, Neuro, Cardio), Component (Software), Deployment (Cloud), End-user (Hospital, ASC), & Region - Global Forecast to 2030
The global clinical informatics market, valued at US$198.33 billion in 2023, stood at US$231.45 billion in 2024 and is projected to advance at a resilient CAGR of 16.0% from 2024 to 2030, culminating in a forecasted valuation of US$563.18 billion by the end of the period. Technological advancements in clinical informatics solutions, the rising need for improved data standardization, and the growing adoption of integrated solutions in clinical applications are key factors driving the market growth.
- Published: December 2024
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
